Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel contributors to B cell activation during inflammatory CNS demyelination; An oNGOing process. | Int J Med Sci | 2022 | 34975310 | PubTator, text mining | PubMed |
| Nc886 promotes renal cancer cell drug-resistance by enhancing EMT through Rock2 phosphorylation-mediated β-catenin nuclear translocation. | Cell Cycle | 2022 | 34974812 | PubTator, text mining | PubMed |
| TH17 cells and corticosteroid insensitivity in severe asthma. | J Allergy Clin Immunol | 2022 | 34953791 | PubTator, text mining | PubMed |
| Targeting KRAS mutant lung cancer: light at the end of the tunnel. | Mol Oncol | 2022 | 34951114 | PubTator, text mining | PubMed |
| ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis. | JHEP Rep | 2022 | 34917911 | PubTator, text mining | PubMed |
| Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. | J Cell Mol Med | 2022 | 34907642 | PubTator, text mining | PubMed |
| PEG-PEI/siROCK2 inhibits Aβ42-induced microglial inflammation via NLRP3/caspase 1 pathway. | Neuroreport | 2022 | 34874326 | PubTator, text mining | PubMed |
| High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma. | Transl Oncol | 2022 | 34837846 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts as cellular vehicles in endometrial cancer cell migration. | Oncol Lett | 2022 | 34820002 | PubTator, text mining | PubMed |
| CD38 plays an age-related role in cholinergic deregulation of airway smooth muscle contractility. | J Allergy Clin Immunol | 2022 | 34800431 | PubTator, text mining | PubMed |
| Advancements in the identification of EV derived mRNA biomarkers for liquid biopsy of clear cell renal cell carcinomas. | Urology | 2022 | 34793840 | PubTator, text mining | PubMed |
| Smoking-associated upregulation of CBX3 suppresses ARHGAP24 expression to activate Rac1 signaling and promote tumor progression in lung adenocarcinoma. | Oncogene | 2022 | 34785774 | PubTator, text mining | PubMed |
| Increased expression of Rho-associated protein kinase 2 confers astroglial Stat3 pathway activation during epileptogenesis. | Neurosci Res | 2022 | 34740726 | PubTator, text mining | PubMed |
| Inhibition of RhoA/MRTF-A signaling alleviates nucleus pulposus fibrosis induced by mechanical stress overload. | Connect Tissue Res | 2022 | 34420462 | PubTator, text mining | PubMed |
| The Outcomes of Small-Molecule Kinase Inhibitors and the Role of ROCK2 as a Molecular Target for the Treatment of Alzheimer's Disease. | CNS Neurol Disord Drug Targets | 2022 | 34414875 | PubTator, text mining | PubMed |
| Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes. | Mol Ther | 2022 | 34371182 | PubTator, text mining | PubMed |
| Extracellular Vesicles as an Emerging Treatment Option for Intervertebral Disc Degeneration: Therapeutic Potential, Translational Pathways, and Regulatory Considerations. | Adv Healthc Mater | 2022 | 34297485 | PubTator, text mining | PubMed |
| RhoA/ROCK-1 Signaling Pathway and Oxidative Stress in Coronary Artery Disease Patients. | Braz J Cardiovasc Surg | 2022 | 34236817 | PubTator, text mining | PubMed |
| Rac-maninoff and Rho-vel: The symphony of Rho-GTPase signaling at excitatory synapses. | Small GTPases | 2022 | 33955328 | PubTator, text mining | PubMed |
| Letter to the Editor regarding the article "Relation of ADRB3, GEF, ROCK2 gene polymorphisms to clinical findings in overactive bladder". | World J Urol | 2022 | 33439276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=53